Will (177)Lu-DOTATATE Treatment Become More Effective in Salvage Meningioma Patients, When Boosting Somatostatin Receptor Saturation? A Promising Case on Intra-arterial Administration

Somatostatin receptor subtype 2 upregulation is very common in meningiomas, and the use of peptide receptor radionuclide therapy (PRRT) is recognized in recent European guidelines, with long-term stable disease and a long overall survival. Treatment efficacy of radionuclide treatments is correlated...

Descripción completa

Detalles Bibliográficos
Autores principales: Braat, A. J. A. T., Snijders, T. J., Seute, T., Vonken, E. P. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775534/
https://www.ncbi.nlm.nih.gov/pubmed/31187231
http://dx.doi.org/10.1007/s00270-019-02262-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775534/
https://www.ncbi.nlm.nih.gov/pubmed/31187231
http://dx.doi.org/10.1007/s00270-019-02262-1

Ejemplares similares